Skip to content
★ Sign in to follow
SM

Saakshi Medtech and Panels Limited Stock: price and insider trades · India

IN·Mcap ₹6.7BHealth Care

No insider purchase over the last 90 days. The latest, by ANIKET VIJAY LATKAR, was filed 21 Jan 2026.

Saakshi Medtech and Panels Limited: what insiders have been doing

This page follows insider dealings at Saakshi Medtech and Panels Limited as filed with SEBI (PIT + SAST), a company from the Health Care sector. The last twelve months, up to 20 October 2026, brought 2 filings signed by 2 insiders.

The flow runs one way only: 2 insiders bought (2 purchases totalling €106k) and nobody sold on the market. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €101k, bought by Mayuri Aniket Latkar and made public on 21 January 2026. The buyers include 2 major shareholders.

The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The latest purchase dates back some time: it was published 291 days ago, on 21 January 2026.

For context, the typical company on the same exchange (median of 1,890 companies) published 4 filings over the same period, against 2 filings here. Over the whole record (from 2025), the tally stands at 5 purchases and no sales.

Other companies in the same sector with recent insider buying flagged by our signals: Vivos Inc and Anixa Biosciences Inc. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
5
Thresholds
n/a
Buy Volume
€200,118
5 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Aniket Vijay Latkar3 buys
Mayuri Aniket Latkar2 buys

Since the insiders bought

  • Filed 21 Jan 2026 · 291 days ago · €5,077
    +9.0%
    Entry ₹186.95 · Close at T+90 ₹203.75
  • Filed 21 Jan 2026 · 291 days ago · €101k
    +9.0%
    Entry ₹186.95 · Close at T+90 ₹203.75

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,955 of 26,911 companies
48.2
score / 100
Value
29
Quality
68
FCF yld-1.2%
Earn yld1.8%
EV/EBITDA30.4x
ROE·
Gross mgn44%
Net mgn11%
Debt/EBITDA1.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹377.00
Income statement
Revenue₹1.2B
Gross profit₹512.7M44% margin
EBITDA₹227.6M20% margin
Net income₹122.9M10.6% margin
Balance sheet & cash
Market cap₹6.7B
Total debt₹254.5M
Free Cash Flow-₹80.9M
Last declaration on 21 January 2026
Declarations5 total
  • ▲
    PromotersExecutives
    542,960 INR18SEBI
    3,000 shares@ ₹180.986710.4% of flowEquity SharesSEBI:ee40f036e1a76dcaa8346b1913dea729a97133c5
    Canonical exit: 21 Apr 2026 (T+90)
  • ▲
    PromotersExecutives
    11M INR24SEBI
    59,400 shares@ ₹182.462167.0% of flowEquity SharesSEBI:9f8a17cfcd47acbcb6f5b1ae604161371e573f01
    Canonical exit: 21 Apr 2026 (T+90)
  • ▲
    Executives
    2M INR6SEBI
    12,000 shares@ ₹176.4442.0% of flowEquity SharesSEBI:7e410e5b9966683e9628616cc18bbe4e63e0598d
    Canonical exit: 9 Dec 2025 (T+90)
  • ▲
    Executives
    5M INR17SEBI
    24,000 shares@ ₹209.42533.0% of flowEquity SharesSEBI:c561d8f3960501e073b6302be21ae3bc6cbb28c0
    Canonical exit: 1 Oct 2025 (T+90)
  • ▲
    Executives
    2M INR19SEBI
    11,400 shares@ ₹205.0047.6% of flowEquity SharesSEBI:15d9378c81a53a0c0f76c6dccba96a98704c4de1
    Canonical exit: 1 Oct 2025 (T+90)

5 of 5 declarations

About Saakshi Medtech and Panels Limited

Saakshi Medtech and Panels Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM exchange.